Duan, Yinkai http://orcid.org/0000-0002-0544-7413
Zhou, Hao
Liu, Xiang http://orcid.org/0000-0001-5498-6942
Iketani, Sho http://orcid.org/0000-0002-3733-9556
Lin, Mengmeng http://orcid.org/0000-0002-8072-6615
Zhang, Xiaoyu
Bian, Qucheng
Wang, Haofeng http://orcid.org/0000-0001-8175-5621
Sun, Haoran
Hong, Seo Jung
Culbertson, Bruce http://orcid.org/0000-0002-1489-1348
Mohri, Hiroshi http://orcid.org/0000-0003-3101-7625
Luck, Maria I.
Zhu, Yan
Liu, Xiaoce
Lu, Yuchi
Yang, Xiuna http://orcid.org/0000-0003-3443-9815
Yang, Kailin
Sabo, Yosef http://orcid.org/0000-0002-4973-8247
Chavez, Alejandro http://orcid.org/0000-0001-5626-7140
Goff, Stephen P. http://orcid.org/0000-0002-9679-0582
Rao, Zihe http://orcid.org/0000-0001-9866-2384
Ho, David D. http://orcid.org/0000-0003-1627-149X
Yang, Haitao http://orcid.org/0000-0002-1875-3268
Article History
Received: 6 December 2022
Accepted: 5 September 2023
First Online: 11 September 2023
Competing interests
: S.I., A.C. and D.D.H. are inventors on patent applications related to the development of inhibitors against the SARS-CoV-2 3CL protease. D.D.H. is a co-founder of TaiMed Biologics and RenBio, consultant to WuXi Biologics and Brii Biosciences, and board director for Vicarious Surgical.